2017
DOI: 10.1111/1753-0407.12604
|View full text |Cite
|
Sign up to set email alerts
|

Lifetime cost for type 2 diabetes mellitus in Singapore

Abstract: Even though T2DM patients have a lower life expectancy, T2DM is associated with substantially higher lifetime medical costs. Delaying the onset of T2DM, especially in the young, may lead to lower lifetime medical expenses. If prevention costs can be kept sufficiently low, effective T2DM prevention efforts would likely lead to a reduction in long-term medical costs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“… 3 In Singapore, the prevalence of diabetes has increased from 8.2% in 2004 to 11.3% in 2010 and is projected to increase to 15% by 2050. 4 The rate of all diabetes-related major lower extremity amputation (LEA) has increased from 11.0/100 000 population in 2008 to 13.3/100 000 in 2013 and according to the latest Organization for Economic Co-operation and Development (OECD) Report , 5 , 6 major LEA rates in Singapore are 2 to 3 fold higher than that in western countries – the highest in the world. The magnitude of the disease burden from DFU places considerable demands on the local healthcare settings.…”
Section: Introductionmentioning
confidence: 99%
“… 3 In Singapore, the prevalence of diabetes has increased from 8.2% in 2004 to 11.3% in 2010 and is projected to increase to 15% by 2050. 4 The rate of all diabetes-related major lower extremity amputation (LEA) has increased from 11.0/100 000 population in 2008 to 13.3/100 000 in 2013 and according to the latest Organization for Economic Co-operation and Development (OECD) Report , 5 , 6 major LEA rates in Singapore are 2 to 3 fold higher than that in western countries – the highest in the world. The magnitude of the disease burden from DFU places considerable demands on the local healthcare settings.…”
Section: Introductionmentioning
confidence: 99%
“…Type 2 diabetes (T2DM) accounts for 99% of all diagnosed cases of diabetes (5). The lifetime medical expenditure of patients with diabetes was shown to be 5.6 times higher than that of patients with nondiabetes (6). Nationally, healthcare spending for diabetes is estimated to increase from US$787 million in 2010 to US $1,867 million in 2050 (7).…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes is expected to impose a massive economic burden on individuals and countries around the world due to the high risk of mortality [4,5]. It has been con rmed that cardiovascular diseases (CVDs) [6], kidney failure [7], and some types of site-speci c cancer [8] are the most common complications of T2DM that often arise together, which could collectively lead to a decline in life expectancy and even death [9].…”
Section: Introductionmentioning
confidence: 99%